Status
Conditions
Treatments
About
To investigate the characteristics of treatment responders to galantamine.
Full description
The purposes of this study are:
to investigate the characteristics of treatment responders to galantamine by examining the clinical response of galantamine in patients with mild to moderate AD for 52 weeks. to examine the specific cognitive sub-domains that are more sensitive to galantamine administration.
Enrollment
Sex
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
66 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal